mTORC inhibitor Sirolimus deprograms monocytes in "cytokine storm" in SARS-CoV2 secondary hemophagocytic lymphohistiocytosis- like syndrome

Clin Immunol. 2020 Sep:218:108539. doi: 10.1016/j.clim.2020.108539. Epub 2020 Jul 13.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • COVID-19*
  • Humans
  • Lymphohistiocytosis, Hemophagocytic*
  • Monocytes
  • RNA, Viral
  • SARS-CoV-2
  • Sirolimus

Substances

  • RNA, Viral
  • Sirolimus